Wasn't it stated our interim data for the Brazil trial is expected in November? The USFDA slow walk has been pretty effective, unfortunately, but the trial data from 4 weekly treatments should put an end to that. Hoping a couple EUAs and that data along the way will serve as the build-up to a conclusive statement once and for all. Will the dirty USFDA cave in to the reality along the way or will they steadfastly remain a BP lapdog until there is nowhere to hide?